SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001247409-04-000013
Filing Date
2004-12-29
Accepted
2004-12-29 14:23:12
Documents
1
Period of Report
2004-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3107
  Complete submission text file 0001247409-04-000013.txt   4995
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELLEGY PHARMACEUTICALS INC 349 OYSTER POINT BLVD #200 S. SAN FRANCISCO CA 94080
Business Address 6506162200
KARLIN DAVID A (Reporting) CIK: 0001247409 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 041230645